CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-14 | Flynn Sean C. SVP, General Counsel | Sale | −106 | $37.45 | $4K | 4,467 |
| 2023-12-14 | Wotton Paul K Director | Sale | −5,000 | $37.31 | $187K | 26,802 |
| 2023-12-14 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +12,000 | $3.57 | $43K | 181,985 |
| 2023-12-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −12,000 | $37.12 | $445K | 169,985 |
| 2023-12-14 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +12,000 | 0 | ||
| 2023-12-13 | Flynn Sean C. SVP, General Counsel | Sale | −1,432 | $34.20 | $49K | 4,573 |
| 2023-12-13 | Colangelo Dominick President and CEO | Gift 10b5-1 | −6,757 | 169,985 | ||
| 2023-12-13 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +12,000 | $3.57 | $43K | 181,985 |
| 2023-12-13 | Colangelo Dominick President and CEO | Sale 10b5-1 | −12,000 | $34.03 | $408K | 169,985 |
| 2023-12-13 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +12,000 | 12,000 | ||
| 2023-12-07 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +12,000 | $3.57 | $43K | 188,742 |
| 2023-12-07 | Colangelo Dominick President and CEO | Sale 10b5-1 | −12,000 | $33.84 | $406K | 176,742 |
| 2023-12-07 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +12,000 | 24,000 | ||
| 2023-12-06 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +12,397 | $3.57 | $44K | 189,139 |
| 2023-12-06 | Colangelo Dominick President and CEO | Sale 10b5-1 | −12,397 | $34.43 | $427K | 176,742 |
| 2023-12-06 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +12,397 | 36,000 | ||
| 2023-11-30 | Halpin Michael Chief Operating Officer | Option exercise 10b5-1 | +17,447 | $7.20 | $126K | 18,274 |
| 2023-11-30 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −17,447 | $35.41 | $618K | 827 |
| 2023-11-30 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +17,447 | 3,132 | ||
| 2023-11-20 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +5,000 | $10.95 | $55K | 58,007 |
Page 34 of 75 · 1,497 trades